HPV疫苗改进QI项目

A. Agulto, Katherine Mohr, L. Gibbons, R. Lancey
{"title":"HPV疫苗改进QI项目","authors":"A. Agulto, Katherine Mohr, L. Gibbons, R. Lancey","doi":"10.1542/PEDS.147.3_MEETINGABSTRACT.630-A","DOIUrl":null,"url":null,"abstract":"Background: HPV infects one-fourth of people in the USA. The HPV vaccine protects against 9 oncogenic strains of HPV, including HPV-16 & 18, which cause 70% of cervical cancers. It is the only available vaccine that prevents cancer, including cervical, vaginal, vulvar, penile, anal, and oropharyngeal cancers. The American Cancer Society recommends the vaccine for boys and girls ages 9-45, yet less than 50% are vaccinated. This resident-led quality improvement project aimed to increase the vaccine initiation and completion rate of eligible patients in …","PeriodicalId":228253,"journal":{"name":"Section on Advances in Therapeutics and Technology Program","volume":"42 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"HPV Vaccine Improvement QI Project\",\"authors\":\"A. Agulto, Katherine Mohr, L. Gibbons, R. Lancey\",\"doi\":\"10.1542/PEDS.147.3_MEETINGABSTRACT.630-A\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: HPV infects one-fourth of people in the USA. The HPV vaccine protects against 9 oncogenic strains of HPV, including HPV-16 & 18, which cause 70% of cervical cancers. It is the only available vaccine that prevents cancer, including cervical, vaginal, vulvar, penile, anal, and oropharyngeal cancers. The American Cancer Society recommends the vaccine for boys and girls ages 9-45, yet less than 50% are vaccinated. This resident-led quality improvement project aimed to increase the vaccine initiation and completion rate of eligible patients in …\",\"PeriodicalId\":228253,\"journal\":{\"name\":\"Section on Advances in Therapeutics and Technology Program\",\"volume\":\"42 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section on Advances in Therapeutics and Technology Program\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1542/PEDS.147.3_MEETINGABSTRACT.630-A\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section on Advances in Therapeutics and Technology Program","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1542/PEDS.147.3_MEETINGABSTRACT.630-A","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:HPV感染了美国四分之一的人。HPV疫苗可以预防9种致癌的HPV毒株,包括HPV-16和18,这两种毒株导致70%的宫颈癌。它是唯一可用的预防癌症的疫苗,包括宫颈癌、阴道癌、外阴癌、阴茎癌、肛门癌和口咽癌。美国癌症协会建议9-45岁的男孩和女孩接种疫苗,但只有不到50%的人接种了疫苗。这个由居民主导的质量改进项目旨在提高符合条件的患者在…
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
HPV Vaccine Improvement QI Project
Background: HPV infects one-fourth of people in the USA. The HPV vaccine protects against 9 oncogenic strains of HPV, including HPV-16 & 18, which cause 70% of cervical cancers. It is the only available vaccine that prevents cancer, including cervical, vaginal, vulvar, penile, anal, and oropharyngeal cancers. The American Cancer Society recommends the vaccine for boys and girls ages 9-45, yet less than 50% are vaccinated. This resident-led quality improvement project aimed to increase the vaccine initiation and completion rate of eligible patients in …
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Infant with Thiamine Deficiency from a Rare Cause Novel Wound Dressing Facilitates Rapid Detection of Infections Dupilumab Was Well Tolerated and Significantly Improved Atopic Dermatitis in Children Aged ≥ 6 to < 12 Years: Results From the LIBERTY AD PEDS Phase 3 Trial Efficacy And Safety Of Crisaborole In Patients Aged 3 Months To 17 Years With Mild-To-Moderate Atopic Dermatitis Optimizing Coping during Venipuncture Procedures with Virtual Reality in the Pediatric Emergency Department: A Randomized Controlled Trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1